- Home
- ETON vs WIMI Comparison
ETON vs WIMI Comparison
Compare ETON & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | WIMI |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.8M | 38.3M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ETON | WIMI |
|---|---|---|
| Price | $16.84 | $2.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $29.67 | N/A |
| AVG Volume (30 Days) | ★ 277.8K | 76.0K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.43 |
| Revenue | ★ $70,316,000.00 | $61,329,146.00 |
| Revenue This Year | $113.27 | N/A |
| Revenue Next Year | $36.70 | N/A |
| P/E Ratio | ★ N/A | $2.03 |
| Revenue Growth | ★ 102.77 | N/A |
| 52 Week Low | $11.09 | $2.24 |
| 52 Week High | $23.00 | $9.66 |
Technical Indicators
Market Signals| Indicator | ETON | WIMI |
|---|---|---|
| Relative Strength Index (RSI) | 49.52 | 39.62 |
| Support Level | $16.13 | $2.77 |
| Resistance Level | $17.05 | $3.26 |
| Average True Range (ATR) | 0.76 | 0.16 |
| MACD | 0.16 | 0.04 |
| Stochastic Oscillator | 79.06 | 28.56 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.